Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
Z Gerontol Geriatr ; 48(1): 49-51, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24271146

ABSTRACT

Bilateral leg edema is a frequent symptom in older people and an important concern in geriatric medicine. Further evaluation is frequently not performed and simple therapy with diuretics is prescribed. Particularly in older patients, long-term use of diuretics can lead to severe electrolyte imbalances, volume depletion, and falls. In this case report we want to focus the physicians' attention on the necessity to determine the cause and show a correspondingly effective treatment for bilateral leg edema in older people. A thorough approach is required to recognize diseases and to avoid adverse drug events as geriatric patients often show an atypical presentation or minor symptoms. The cause of swollen legs is often multifactorial; therefore, the patient's individual history and an appropriate physical examination are important. Depending on the clinical symptoms, evaluation including basic laboratory tests, urinalysis, chest radiography, and echocardiogram may be indicated. The most probable cause of bilateral edema in older patients is chronic venous insufficiency. Heart failure is also a common cause. Other systemic causes such as renal disease or liver disease are much rarer. Antihypertensive and anti-inflammatory drugs can frequently cause leg edema, but the incidence of drug-induced leg swelling is unknown. With the help of this special case we tried to develop an approach to the diagnosis of symmetric leg edema in older patients, a problem frequently neglected in geriatric medicine.


Subject(s)
Edema/diagnosis , Edema/etiology , Heart Diseases/complications , Ibuprofen/adverse effects , Venous Insufficiency/complications , Aged, 80 and over , Chronic Disease , Diagnosis, Differential , Edema/therapy , Female , Humans
2.
Spectrochim Acta A Mol Biomol Spectrosc ; 57(10): 2049-60, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11666084

ABSTRACT

Recent advances on the use of mesoporous and mesostructured materials for electronic and optical applications are reported. The focus is on materials which are processed by block-copolymer templating of silica under weakly acidic conditions and by employing dip- and spin-coating as well as soft lithographic methods to bring them into a well-defined macroscopic shape. Several chemical strategies allow the mesostructure architecture to be used for electronic/optical applications: Removal of the block-copolymers results in highly porous, mechanically and thermally robust materials which are promising candidates for low dielectric constant materials. Since the pores are easily accessible, these structures are also ideal hosts for optical sensors, when suitable are incorporated during synthesis. For example, a fast response optical pH sensor was implemented on this principle. As-synthesized mesostructured silica/block-copolymer composites, on the other hand, are excellently suited as host systems for laser dyes and photochromic molecules. Laser dyes like rhodamine 6G can be incorporated during synthesis in high concentrations with reduced dimerization. This leads to very-low-threshold laser materials which also show a good photostability of the occluded dye. In the case of photochromic molecules, the inorganic-organic nanoseparation enables a fast switching between the colorless and colored form of a spirooxazine molecule, attributed to a partitioning of the dye between the block-copolymer chains. The spectroscopic properties of these dye-doped nanocomposite materials suggest a silica/block-copolymer/dye co-assembly process, whereby the block-copolymers help to highly disperse the organic dye molecules.


Subject(s)
Electronics , Lasers , Spectrophotometry/methods , Fluorescent Dyes/pharmacology , Hydrogen-Ion Concentration , Rhodamines/pharmacology , Time Factors
4.
Clin Nephrol ; 54(1): 35-44, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10939755

ABSTRACT

BACKGROUND: Dialysis patients are at risk of developing trace element imbalances. To further elucidate the origin of these potential trace element imbalances, plasma and dialysis fluids concentrations of the elements barium (Ba), calcium (Ca), copper (Cu), lead (Pb), magnesium (Mg), strontium (Sr) and zinc (Zn) of seven maintenance dialysis patients were investigated. PATIENTS AND METHODS: In each hemodialysis session 10 to 15 samples of each, whole blood and dialysis liquid before and after passing the artificial kidney were collected. Concentrations of elements were determined by inductively coupled plasma mass spectrometry following strict quality control schemes to guarantee the accuracy and precision of the results. RESULTS: Plasma concentrations of Cu and Zn continuously increased during hemodialysis. Plasma Cu remained within the reference range for healthy adults, whereas plasma Zn was always at or below the reference range in our patients. The behavior of Ca and Sr exhibited extraordinarily strong similarities both in plasma and dialysis liquids, although concentrations of Sr are approximately 2000 times lower. Plasma Ca and Sr were at or above the upper level of the reference range. Plasma Mg concentrations decreased during clinical treatment, but were at the end of dialysis still more than 50% higher than the high end of the reference range. Although concentrations of Ba in dialysis fluids were approximately 10 times lower than in plasma, plasma Ba concentrations (approximately 23 microg/l) were significantly elevated compared to plasma Ba of healthy adults. Initial concentrations of Pb in plasma (0.74 microg/l) were increased by approximately 15% during the clinical treatment and were always higher than the high limit of the reference range. Dialysis liquids had approximately the same Pb concentrations (0.5 to 1.3 microg/l) as found in the plasma of our patients but with higher concentrations at the inlet of the dialyzer. CONCLUSION: This study could give an insight into the kinetics of trace element concentrations during dialysis, the clinical relevance of which needs to be further elucidated.


Subject(s)
Renal Dialysis , Trace Elements/metabolism , Adult , Aged , Barium/metabolism , Calcium/metabolism , Copper/metabolism , Female , Hemodialysis Solutions/chemistry , Humans , Lead/metabolism , Male , Middle Aged , Strontium/metabolism , Zinc/metabolism
5.
Blood Purif ; 18(2): 138-43, 2000.
Article in English | MEDLINE | ID: mdl-10838473

ABSTRACT

BACKGROUND: Hemodialysis (HD) patients are at risk of developing trace element imbalances. METHODS: The 12 trace elements Cd, Co, Cs, Cu, La, Mg, Mo, Pb, Rb, Sr, Tl and Zn were determined in the plasma (n = 52) of 6 chronic HD patients before and after HD sessions by inductively coupled plasma mass spectrometry. Plasma trace element concentrations were monitored for 6 months. Baseline data have been compared to the concentrations at the end of the observation period to identify a potential reduction or accumulation of trace elements in HD patients. RESULTS: Plasma Cd, Co and Pb levels were about 10 times higher than in healthy adults. Concentrations of Co and Pb increased during HD sessions, whereas plasma Co and Cd increased during the study period of 6 months. Plasma Cs, Mg, Mo and Rb continuously decreased in all patients. For plasma Cu and Zn, a statistically significant rise of their plasma concentrations during HD and during the period of 6 months could be established. Concentrations of La and Tl did not change distinctly. CONCLUSION: This study revealed that plasma trace element concentrations in HD patients are distinctly different compared to that of healthy adults. Elements such as Cs, Mg, Mo and Rb are reduced and Cd, Co and Pb are accumulated in HD patients. Further studies are needed to elucidate the clinical impact of these trace element imbalances.


Subject(s)
Renal Dialysis/adverse effects , Trace Elements/blood , Adult , Aged , Chronic Disease , Female , Follow-Up Studies , Humans , Male , Mass Spectrometry/methods , Renal Insufficiency/blood , Renal Insufficiency/therapy
6.
Science ; 287(5452): 465-8, 2000 Jan 21.
Article in English | MEDLINE | ID: mdl-10642543

ABSTRACT

Mesostructured silica waveguide arrays were fabricated with a combination of acidic sol-gel block copolymer templating chemistry and soft lithography. Waveguiding was enabled by the use of a low-refractive index (1.15) mesoporous silica thin film support. When the mesostructure was doped with the laser dye rhodamine 6G, amplified spontaneous emission was observed with a low pumping threshold of 10 kilowatts per square centimeter, attributed to the mesostructure's ability to prevent aggregation of the dye molecules even at relatively high loadings within the organized high-surface area mesochannels of the waveguides. These highly processible, self-assembling mesostructured host media and claddings may have potential for the fabrication of integrated optical circuits.

7.
Chemphyschem ; 1(2): 90-2, 2000 Sep 15.
Article in English | MEDLINE | ID: mdl-23696285
8.
Nephron ; 83(3): 226-36, 1999.
Article in English | MEDLINE | ID: mdl-10529629

ABSTRACT

BACKGROUND: In the past, nephrologists have been troubled by electrolyte disturbances and consequently focused their attention on the importance of maintaining the concentrations of electrolytes within the normal range. However, information about the potential role of trace elements in chronic renal failure is scarce. METHODS: During hemodialysis sessions, the concentrations of the five alkali metal cations lithium (Li), sodium (Na), potassium (K), rubidium (Rb), and cesium (Cs) have been determined in plasma and dialysis fluids of chronic hemodialysis patients by inductively coupled plasma mass spectrometry (Li, Rb, Cs) and by ion-sensitive electrodes (Na, K). Strict quality control schemes were applied to all analytical procedures to ensure accuracy and precision of the results. RESULTS: The plasma concentrations of the elements Li, Cs, Rb, and K distinctly decreased to 29, 50, 69, and 71%, respectively, of their initial values during hemodialysis. Simultaneously, the concentrations of these elements in dialysis fluids at the outlet of the dialyzer increased approximately 13-fold for Rb, 11-fold for Li, 3-fold for Cs, and 2-fold for K as compared with the inlet values. The concentrations of Na in plasma and dialysis fluids were almost identical and did not change during hemodialysis. CONCLUSIONS: Li, Rb, and Cs were depleted in hemodialysis patients, although the plasma concentrations of these trace elements still remained within the reference ranges for healthy adults. Consequently, further studies are needed to elucidate the clinical importance and long-term effects of these trace element imbalances - for example, CNS disturbances associated with diminished concentrations of Rb - in hemodialysis patients.


Subject(s)
Kidney Failure, Chronic/blood , Kidney Failure, Chronic/therapy , Metals, Alkali/blood , Potassium/blood , Renal Dialysis , Sodium/blood , Adult , Aged , Cesium/analysis , Cesium/blood , Chemistry, Clinical/standards , Dialysis Solutions/administration & dosage , Dialysis Solutions/chemistry , Female , Humans , Lithium/analysis , Lithium/blood , Male , Metals, Alkali/analysis , Middle Aged , Potassium/analysis , Quality Control , Rubidium/analysis , Rubidium/blood , Sodium/analysis
10.
Int J Oncol ; 15(1): 41-51, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10375592

ABSTRACT

A malignant insulinoma (LOHG-I), a carcinoid of the lung (LOHG-L), a parathyroid adenoma (LOHG-NSA), and a fibroma (LOHG-F) were obtained from a patient with multiple endocrine neoplasia type 1 (MEN1). Long-term cultures were established. Essential neurobiological properties of the cell lines were proven immunocytochemically and by electron microscopy. Molecular analysis of the germline DNA showed a 4 bp deletion in exon 3 of the MEN1 gene. Cytogenetic and CGH analyses of the tumors/tumor cell lines revealed diploidy and balanced and unbalanced structural aberrations different for each tumor. Chromosomes 6q21, 11q and 17q were most frequently involved in clonal structural aberrations.


Subject(s)
Adenoma/genetics , Carcinoid Tumor/genetics , Chromosomes, Human, Pair 11/genetics , DNA, Neoplasm , Fibroma/genetics , Genes, Tumor Suppressor , Insulinoma/genetics , Lung Neoplasms/genetics , Multiple Endocrine Neoplasia Type 1/genetics , Neoplasm Proteins/deficiency , Pancreatic Neoplasms/genetics , Parathyroid Neoplasms/genetics , Proto-Oncogene Proteins , Skin Neoplasms/genetics , Adenoma/pathology , Adrenal Gland Neoplasms/pathology , Adult , Aneuploidy , Carcinoid Tumor/pathology , Chromosome Aberrations , DNA Mutational Analysis , DNA, Neoplasm/genetics , Esophageal Neoplasms/pathology , Fibroma/pathology , Humans , Insulinoma/pathology , Leiomyoma/pathology , Lung Neoplasms/pathology , Male , Multiple Endocrine Neoplasia Type 1/pathology , Neoplasm Proteins/genetics , Neoplasm Proteins/physiology , Nucleic Acid Hybridization , Pancreatic Neoplasms/pathology , Parathyroid Neoplasms/pathology , Pheochromocytoma/pathology , Sequence Deletion , Skin Neoplasms/pathology , Tumor Cells, Cultured
15.
Oncol Rep ; 6(1): 29-32, 1999.
Article in English | MEDLINE | ID: mdl-9864396

ABSTRACT

Marked impairment of the cellular immune system predisposes renal transplant recipients to Epstein-Barr virus (EBV) associated clinical syndromes. This can culminate in post-transplantation lymphoproliferative disorders (PTLD) and malignant lymphomas. An unusual PTLD in a 59-year-old renal transplant recipient is reported here. Sonography and CT scan revealed a hypovascular infiltrating tumor mass in the lower pole of the graft which on histopathologic examination revealed a monotonous lymphoid proliferation. T-cell receptor and immunoglobulin heavy chain gene rearrangement as well as immunohistochemical analyses demonstrated a polyclonal origin of atypical lymphatic T- and B-cells. The Epstein-Barr viral genome was detected in the mass by Southern blot analysis, and a primary EBV infection was confirmed by serologic studies. Clinical follow-up showed a tumor-free course till the patient's sudden cardiac death 14 months after the operation.


Subject(s)
Epstein-Barr Virus Infections/transmission , Herpesvirus 4, Human/isolation & purification , Kidney Neoplasms/etiology , Kidney Transplantation/adverse effects , Lymphoma, Non-Hodgkin/etiology , Postoperative Complications/pathology , Adult , B-Lymphocytes/pathology , Contact Tracing , Cytomegalovirus Infections/complications , Epstein-Barr Virus Infections/complications , Graft Rejection/drug therapy , Herpes Simplex/complications , Humans , Immunosuppression Therapy/adverse effects , Kidney Neoplasms/surgery , Kidney Neoplasms/virology , Lymphoma, Non-Hodgkin/surgery , Lymphoma, Non-Hodgkin/virology , Male , Middle Aged , Neoplastic Stem Cells/pathology , Nephrectomy , Postoperative Complications/etiology , Pyelonephritis/surgery , T-Lymphocytes/pathology , Tissue Donors
17.
J Clin Endocrinol Metab ; 83(8): 2742-8, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9709941

ABSTRACT

This study examined the effects of daily oral magnesium (Mg) supplementation on bone turnover in 12 young (27-36 yr old) healthy men. Twelve healthy men of matching age, height, and weight were recruited as the control group. The study group received orally 15 mmol Mg (Magnosolv powder, Asta Medica) daily in the early afternoon with 2-h fasting before and after Mg intake. Fasting blood and second void urine samples were collected in the early morning on days 0, 1, 5, 10, 20, and 30, respectively. Total and ionized Mg2+ and calcium (Ca2+), and intact PTH (iPTH) levels were determined in blood samples. Serum biochemical markers of bone formation (i.e. C-terminus of type I procollagen peptide and osteocalcin) and resorption (i.e. type I collagen telopeptide) and urinary Mg level adjusted for creatinine were measured. In these young males, 30 consecutive days of oral Mg supplementation had no significant effect on total circulating Mg level, but caused a significant reduction in the serum ionized Mg+ level after 5 days of intake. The Mg supplementation also significantly reduced the serum iPTH level, which did not appear to be related to changes in serum Ca2+ because the Mg intake had no significant effect on serum levels of either total or ionized Ca2+. There was a strong positive correlation between serum iPTH and ionized Mg2+ (r = 0.699; P < 0.001), supporting the contention that decreased serum iPTH may be associated with the reduction in serum ionized Mg2+. Mg supplementation also reduced levels of both serum bone formation and resorption biochemical markers after 1-5 days, consistent with the premise that Mg supplementation may have a suppressive effect on bone turnover rate. Covariance analyses revealed that serum bone formation markers correlated negatively with ionized Mg2+ (r = -0.274 for type I procollagen peptide and -0.315 for osteocalcin), but not with iPTH or ionized Ca2+. Thus, the suppressive effect on bone formation may be mediated by the reduction in serum ionized Mg2+ level (and not iPTH or ionized Ca2+). In summary, this study has demonstrated for the first time that oral Mg supplementation in normal young adults caused reductions in serum levels of iPTH, ionized Mg2+, and biochemical markers of bone turnover. In conclusion, oral Mg supplementation may suppress bone turnover in young adults. Because increased bone turnover has been implicated as a significant etiological factor for bone loss, these findings raise the interesting possibility that oral Mg supplementation may have beneficial effects in reducing bone loss associated with high bone turnover, such as age-related osteoporosis.


Subject(s)
Bone Remodeling/drug effects , Dietary Supplements , Magnesium/administration & dosage , Adult , Biomarkers/blood , Calcium/blood , Collagen/blood , Collagen Type I , Humans , Magnesium/blood , Male , Osteocalcin/blood , Parathyroid Hormone/blood , Peptide Fragments/blood , Peptides/blood , Procollagen/blood
18.
Oncol Rep ; 5(4): 853-6, 1998.
Article in English | MEDLINE | ID: mdl-9625831

ABSTRACT

A 43-year-old caucasian male diabetic presented with purulent cough and a history of weight-loss, elevated temperature, night-sweat and dyspnea. Four years previously, the patient had undergone a 12-month antimycobacterial regimen because of pulmonary mycobacterium kansasii (MK) disease of the left upper lobe (LUL). Treatment had led to complete recovery with the exception of minor fibrous residuals in the involved pulmonary segments. Chest radiograph and computed tomography (CT), performed on recent admission, revealed a dense infiltration of these residual-containing segments. Microbiological evaluation of bronchial brushings, aspirates and histology of the transbronchial biopsies indicated a relapse of pulmonary MK disease. Although antimycobacterial treatment was started immediately, therapeutic effects were only minimal and remained to be limited to the initial phase of the treatment. After four weeks of treatment, the patient's general condition worsened again. Follow-up CT of the lung showed a marked increase of the infiltration in the left apicoposterior lobe and re-bronchoscopy showed a tumorous protrusion of the bronchial wall involving the apicoposterior segment ostium, a finding which was not seen in the previous bronchoscopy. Histology of the transbronchial biopsies revealed a carcinoma mainly from large-cell type.


Subject(s)
Carcinoma, Non-Small-Cell Lung/complications , Diabetes Mellitus, Type 1/complications , Lung Diseases/complications , Lung Neoplasms/complications , Mycobacterium Infections, Nontuberculous/complications , Mycobacterium kansasii , Carcinoma, Non-Small-Cell Lung/diagnostic imaging , Humans , Lung Diseases/diagnostic imaging , Lung Neoplasms/diagnostic imaging , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/diagnostic imaging , Recurrence , Tomography, X-Ray Computed
19.
Acta Orthop Scand ; 69(2): 144-6, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9602771

ABSTRACT

Deep venous thrombosis (DVT) and pulmonary embolism (PE) are less common after knee arthroscopy than after elective hip and knee arthroplasties. There is no consensus on the optimal prophylaxis. In this prospective cohort study, we used ultrasound, phlebography and lung scan pre- and postoperatively to assess the incidence of thromboembolic complications in 101 consecutive patients who underwent knee arthroscopy. Preoperatively, patients were screened for typical risk factors for DVT such as age, obesity, varicose veins, contraceptive pills and nicotine abuse. All patients received a once-daily injection of 5000 IU of low molecular weight heparin, at least 12 hours prior to surgery. 5 weeks after surgery, the same screening tests were repeated. In 12 of the 101 patients either DVT or PE was diagnosed. DVT occurred in 8 cases, 4 of which were silent and 4 symptomatic. The number of PEs was 9, 8 silent and 1 symptomatic. We found no correlation between DVT or PE and individual clinical risk factors, but there was a tendency towards the development of DVT and PE, with a higher number of risk factors. We found no correlation between DVT and intraoperative risk factors such as use of a tourniquet, type of anesthesia or duration of surgery. The relatively high rate of thromboembolic events after knee arthroscopy in our study suggests the need of all patients for routine use of thromboprophylaxis, probably in a higher dose than given.


Subject(s)
Endoscopy , Knee Joint/surgery , Postoperative Complications , Thromboembolism/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Arthroscopy , Female , Humans , Joint Diseases/surgery , Male , Middle Aged , Prospective Studies , Risk Factors
20.
J Neurocytol ; 27(3): 175-86, 1998 Mar.
Article in English | MEDLINE | ID: mdl-10640177

ABSTRACT

Pheochromocytomas are rare tumours, with an incidence of 1-2 per million which arise from chromaffin cells of the adrenal medulla. They occur sporadically or as part of dominantly inherited cancer syndromes like multiple endocrine neoplasia 2 (MEN2A and 2B) and others. Continuous cell lines, not available so far, are essential tools for studies in these tumours. A continuous cell line (KNA) was established from a sporadic pheochromocytoma of the right adrenal gland of a 73-year-old woman. The KNA cells grow as suspensions of spheroids and show the morphological and immunocytochemical characteristics of neuronal chromaffin cells, such as neuroendocrine granules, and positive reactions to chromogranin- and related peptide-, neuron specific enolase and vasoactive intestinal peptide antibodies. Neurite-like processes are formed after addition of nerve growth factor. Chromosomal analyses revealed a diploid (46,XX,n = 50) to hypodiploid (43-45,XX,n = 15) karyotype. In hypodiploid metaphases most frequently #19, #17, #21 and #22 were missing. Chromosome arms 1p and 4q showed apparently consistent interstitial deletions: 6q, 8q, 13q and 22q showed clonal interstitial deletions. The cell line shows a heterozygous sequence variant TGC (cysteine) to TGG (tryptophan) in codon 611 in exon 10 of the RET proto-oncogene. So far, PC-12, a rat adrenal pheochromocytoma, has been the only continuous pheochromocytoma cell line available. KNA represents the first report on a human continuous pheochromocytoma cell line, the first report of structural chromosome aberrations in pheochromocytomas and the first report of a RET mutation TGC to TGG in exon 10 of the RET proto-oncogene in a sporadic pheochromocytoma.


Subject(s)
Adrenal Gland Neoplasms/pathology , Drosophila Proteins , Pheochromocytoma/pathology , Tumor Cells, Cultured , Adrenal Gland Neoplasms/genetics , Adrenal Gland Neoplasms/metabolism , Aged , Amino Acid Substitution , Animals , Biomarkers, Tumor/analysis , Catecholamines/analysis , Chromogranin A , Chromogranins/analysis , Chromosome Aberrations , Cytoplasmic Granules/chemistry , Cytoplasmic Granules/ultrastructure , Dopamine beta-Hydroxylase/analysis , Exons/genetics , Female , Humans , Male , Mice , Mice, Nude , Neoplasm Proteins/genetics , Neoplasm Transplantation , Nerve Growth Factor/pharmacology , Neuropeptides/analysis , Pheochromocytoma/genetics , Pheochromocytoma/metabolism , Ploidies , Point Mutation , Proto-Oncogene Mas , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-ret , Proto-Oncogenes , Receptor Protein-Tyrosine Kinases/genetics , Tumor Cells, Cultured/chemistry , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/transplantation , Tumor Cells, Cultured/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL